NCT04736095

Brief Summary

• three-dimensional saline infusion sonohysterography (3D SIS) was performed in all cases. A sterile Cuscoe speculum was passed, the cervix visualized and cleaned with sterile chlorhexidine solution. A 3.3 mm soft plastic paediatric naso-gastric suction catheter was then passed through the cervix into the uterine cavity without grasping the cervix.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2021

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 29, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 3, 2021

Completed
4 days until next milestone

Study Start

First participant enrolled

February 7, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2021

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 17, 2021

Completed
Last Updated

May 25, 2021

Status Verified

May 1, 2021

Enrollment Period

3 months

First QC Date

January 29, 2021

Last Update Submit

May 21, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • The accuracy of 3D ultrasound in doiagnosis of submucous myomas in comparison to hysteroscopy

    How many women will be diagnosed by 3D US to have submucous myoma

    one week

Study Arms (2)

3D ultrasound for diagnosis of submucous myomas

Diagnostic Test: 3D Ultrasound

Hysteroscopy for diagnosis of submucous myoma

Diagnostic Test: Hysteroscopy

Interventions

3D UltrasoundDIAGNOSTIC_TEST

Doing 3D ultrasound for diagnosis of submucous myoma

3D ultrasound for diagnosis of submucous myomas
HysteroscopyDIAGNOSTIC_TEST

Doing hysteroscopy for diagnosis of submucous myoma

Hysteroscopy for diagnosis of submucous myoma

Eligibility Criteria

Age20 Years - 60 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailswomen with submucous myomas
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Women between 20 and 60 years with abnormal uterine bleeding

You may qualify if:

  • Women between 20 and 60 years with abnormal uterine bleeding in form of heavy menstrual bleeding, irregular and heavy menstrual bleeding) diagnosed on non-enhanced two-dimensional ultrasonography with submucous fibroids.
  • Absence of STD, PID, active vaginal bleeding.

You may not qualify if:

  • Presence of general cause of abnormal uterine bleeding
  • History of drug use that can cause vaginal bleeding (anticoagulants, OCPs, HRT)
  • History of recent hormonal treatment
  • High risk of undergoing hysteroscopy
  • Vaginal, Vulval causes of bleeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Algazeerah

Giza, Egypt

Location

Aljazeera( Al Gazeera) hospital

Giza, Egypt

Location

MeSH Terms

Conditions

Leiomyoma

Interventions

Hysteroscopy

Condition Hierarchy (Ancestors)

Neoplasms, Muscle TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasms

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Obstetrical and GynecologicalDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeObstetric Surgical ProceduresGynecologic Surgical ProceduresUrogenital Surgical Procedures

Study Officials

  • Mahmoud Alalfy, PhD

    Algezeera hospitaland National Research Centre ,Egypt

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 29, 2021

First Posted

February 3, 2021

Study Start

February 7, 2021

Primary Completion

May 15, 2021

Study Completion

May 17, 2021

Last Updated

May 25, 2021

Record last verified: 2021-05

Locations